KL-6 and poor prognosis in NSCLC patients treated with gefitinib

Lung Cancer. 2008 Jan;59(1):138; author reply 139. doi: 10.1016/j.lungcan.2007.09.017. Epub 2007 Nov 14.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / blood
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Gefitinib
  • Humans
  • Lung Neoplasms / blood
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / mortality
  • Mucin-1 / blood*
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • MUC1 protein, human
  • Mucin-1
  • Quinazolines
  • Gefitinib